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INTRODUCTION
Murine models are broadly used in the field of food allergy to 
ascertain etiology, mechanisms, and preventive or therapeutic 
strategies through studies which would otherwise not be possi-
ble in human patients.1 Induction of oral sensitization to food 
proteins in mice requires the use of adjuvants, such as cholera 
toxin (CT) or staphylococcal enterotoxin B (SB), to overcome 
their strong tendency to develop oral tolerance by promoting 
Th2-polarized immune responses over Th1 responses, which 
produce antigen-specific IgE.2 Subsequent oral challenge with 
the food or allergen can cause gastrointestinal or systemic 
signs, such as diarrhea and shock syndrome, respectively.3
Two main mouse strains with well-defined genetic back-
grounds: BALB/c and C3H have been applied to stablish the in-
duction and effector mechanisms of common food allergens. 
In addition, there are available congenic mice of both strains 
carrying a mutation in toll-like receptor 4 (TLR4), which makes 
them insensitive to lipopolysaccharide (LPS), and thus, to the 
influence of gram-negative bacteria in the gastrointestinal 
tract.4 Studies conducted with these animal models have al-
lowed testing experimentally the intrinsic properties of proteins 
that promote oral sensitization, the differential capacity of aller-
gens to trigger the manifestations of food allergy and the influ-
ence of the food matrix and processing in their allergenic po-
tential.5-7 
However, recognition of proteins as immunogens is strain-de-
pendent, leading to IgE or IgG-mediated responses.8 In fact, 
there are 2 different pathways of systemic murine anaphylaxis 
whose relative importance also depends on the route of admin-
istration and on the characteristics and amounts of antigen 
used to induce the antibody response and the anaphylactic re-
action.3 Furthermore, several studies have documented that 
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susceptibility of mice to orally induced anaphylaxis varies with 
the genetic background.9 In this respect, it should be taken into 
account that the presence of a functional LPS receptor does not 
correlate with the predisposition to sensitization or the severity 
of anaphylaxis, which in turn depend greatly on the allergen 
used.4 Therefore, previous knowledge underlines the need for 
selecting the most appropriate mouse strain for accurate esti-
mation of the sensitizing and eliciting capacity of a particular 
allergen.
Ovalbumin (OVA, Gal d 2) is the most abundant protein in 
egg white and one of its major allergens.10 The importance of 
OVA stems not only from the high prevalence of egg allergy, the 
second more frequent food allergy in children below the age of 
3, which affects up to 1.7% of children and adults,11 but also be-
cause OVA is normally used as a model protein to investigate 
the molecular and cellular mechanisms of allergic sensitization 
and tolerance.12-15
The aim of the present study was to compare the utility of 2 
mouse strains: BALB/c and C3H/HeOuJ for the evaluation of 
the allergenic potential of OVA. For this purpose, IgE, IgG1, and 
IgG2a antibody levels, severity of anaphylaxis, and Th1 and Th2 
responses induced by OVA were assessed. In addition, because 
the mice selected had functional TLR4, we investigated the in-
fluence of LPS contamination on the immunostimulating ca-
pacity of OVA using spleen cell cultures from naïve and sensi-
tized mice of both strains. 
MATERIAL AND METHODS
Mice and proteins
Five-week-old female specific-pathogen-free BALB/c and 
C3H/HeOuJ mice were purchased from Charles River Labora-
tories (Saint Germain sur l´Arbresle, France) and were kept for 
1 week under acclimation at the animal facility before starting 
the experiment. Animals were housed in sterilized cages (5 
mice per cage) in a controlled environment at 22°C with 12-
hour light and 12-hour dark cycles. Bedding was autoclaved 
and changed at least weekly, according to the experimental 
protocols. The cages were only opened inside a laminar flow 
cabinet to maintain the specific pathogen free status during the 
whole experiment. All the mice had ad libitum access to an 
egg-free autoclaved feed (SAFE, Route de Saint Bris, France) 
and water. Diet was composed of vegetable proteins, cereals, 
and a mixture of vitamin and mineral, and did not contain ani-
mal protein. 
The animal facility is committed to complying with the cur-
rent regulations regarding animal welfare, observation of the 
animals’ health, and training of the staff for their care and han-
dling. All protocols involving animals were approved by the 
Bioethical Committee of the CSIC and followed the current EU 
legislation (Directive 2010/63/EU). 
Chemicals
OVA (grade VI, 99% purity) was obtained from Sigma (St. Lou-
is, MO, USA), and its LPS level was quantified by the Pierce® 
LAL Chromogenic Endotoxin Quantitation Kit (Thermo scien-
tific, Waltham, USA; limit of detection 1-0.1 UE/mg), according 
to the manufacturer’s instructions. In order to purify OVA from 
LPS contamination, size exclusion chromatography was car-
ried out.16 For this purpose, a Superdex 75 column (Hiload 
26/60, AP biotech, Uppsala, Sweden) was loaded with 10 mg/
mL OVA in ammonium acetate (0.15 M, pH 6.0) and elution 
was carried out with 2.5 mL/min of this buffer. Ultrafiltration 
with Amicon® (EMD Millipore Corporation, Billerica, MA, USA) 
was used to remove buffer salts. This procedure reduced the 
LPS content of OVA from 446 UE/mg (OVA-LPS) to 1-3 UE/mg 
(OVA-LPS-free).
Experimental design
Sensitization and challenge of mice were performed as de-
scribed by López-Expósito et al.17 BALB/c and C3H/HeOuJ 
mice (5 per group) were sensitized once per week for 6 weeks, 
by gavage with 2 different doses of OVA-LPS-free (1 and 5 mg) 
dissolved in 0.5 mL of 0.2 M bicarbonate with 10 µg of cholera 
toxin (CT) (List Biologicals, Campbell, CA, USA). Naïve mice re-
ceived 10 µg of CT in 0.5 mL of bicarbonate. In week 7, all the 
mice were orally challenged twice with 50 mg of OVA-LPS-free 
30 minutes apart, followed by a systemic challenge with 100 µg 
of OVA-LPS-free intraperitoneally (i.p.) administered, in case 
severe symptoms (≥4) after oral challenge were not observed. 
The severity of anaphylaxis was evaluated by measuring the 
body temperature decrease (rectal thermometer; Panlab, Cor-
nellá, Spain) and scoring clinical signs 30 minutes after each 
dose. Clinical signs were graded by a score scale adapted from 
those of Li et al.18 and Perrier et al.19 as follows: 0=no signs; 1=  
scratching nose and mouth less than 10 times in 15 minutes; 
2=puffiness around eyes and mouth, scratching nose and 
mouth more than 10 times in 15 minutes; 3=wheezing and la-
bored respiration, cyanosis around the mouth and tail, diar-
rhea and difficulty in walking normally; 4=no activity after 
prodding; and 5=death. Thirty minutes after the last challenge, 
mice were sacrificed. Blood samples were collected, and sera 
were recovered and stored at -80°C until analysis. Spleens were 
aseptically removed and immediately processed for splenocyte 
cultures. 
Measurement of antigen-specific immunoglobulins and mast-
cell degranulation 
Blood samples were obtained on days 22 and 36 and after 
challenge (day 42). The specific murine IgE, IgG1, and IgG2a an-
tibodies against OVA were quantified in sera by ELISA.20 Briefly, 
96-well plates were coated with OVA or with rat anti-mouse IgE, 
IgG1, and IgG2a (BD Biosciences, San Diego, CA, USA) for the 
reference curves. After an overnight incubation at 4°C, plates 
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were blocked and incubated overnight at 4°C with serum sam-
ples (1/20 dilution for IgE, 1/5,000 dilution for IgG1, and 1/100 
dilution for IgG2a) or serial dilutions of mouse IgE, IgG1, and Ig-
G2a (BD Biosciences), respectively. Afterward, plates were incu-
bated with biotinylated rat anti-mouse IgE, IgG1, and IgG2a (BD 
Biosciences), followed with avidin-horseradish peroxidase (BD 
Biosciences). The reactions were developed with ABTS (2,2’-azi-
no-bis (3-ethylbenzthiazoline-6-sulfonate)) substrate (Roche, 
Mannheim, Germany) and read at 405 nm.
Mouse mast-cell degranulation was evaluated after challenge 
by measuring serum levels of mouse mast-cell protease 1 
(mMCP-1), a marker of activation of intestinal mast cells, with a 
commercial ELISA kit (eBioscience, San Diego, USA), following 
the manufacturer’s instructions.
Cytokines released following in vitro spleen-cell stimulation
Splenocytes from individual mice were cultured in RPMI 1640 
medium containing 10% of fetal bovine serum, L-glutamine (2 
mM), penicillin (50 U/mL), and streptomycin (50 μg/mL) (all 
from Biowest SAS, Nuaillé, France) at a cellular density of 4×
106 cells/mL in 24-well plates. They were stimulated in tripli-
cate with concanavalin A (2.5 μg/mL), OVA-LPS, or OVA-LPS-
free (200 µg/mL) and culture medium as a control. Cells were 
maintained for 72 hours at 37°C in 5% CO2. Afterward, plates 
were centrifuged and culture supernatants collected and stored 
at -80°C until analysis. IFN-γ, TFN-α, IL-5, IL-10, and IL-13 were 
quantified using cytokine ELISA kits (eBioscience) as outlined 
by the manufacturers. The results were expressed in pg/mL as 
sample means for test replicates.
Statistical analysis
All statistical analyses were performed using GraphPad Prism 
(GraphPad Software Inc., San Diego, CA, USA). Data were ana-
lyzed by one-way analysis of variance (ANOVA) followed by 
Bonferroni’s multiple comparison test, except for clinical sign 
scores, for which the Mann Whitney test was used. A t test was 
carried out to determine if the level of cytokines produced by 
splenocytes were different when stimulated with OVA-LPS-free 
or OVA-LPS. A P value of <0.05 was considered statistically sig-
nificant.
RESULTS
Induction of OVA-specific IgE, IgG1, and IgG2a antibodies
Mice orally sensitized to OVA-LPS-free produced significantly 
higher amounts of IgE and IgG1 than naïve mice and, in general 
terms, there were no significant differences between the 2 doses 
of protein used for sensitization (1 or 5 mg) (Table). The levels of 
OVA-specific IgE did not change from day 22 after the initial 
sensitization, while maximum IgG1 production was detected 
following the last sensitization dose (day 36). IgE and IgG1 re-
sponses were similar in BALB/c and C3H/HeOuJ mice, whereas 
Table. OVA-specific IgE, IgG1, and IgG2a values at days 22, 36, and 42
Day 5 mg 1 mg Naïve
IgE BALB/c 22 977.04a±276.92 873.28a±128.40 0.00b
36 1,194.12a±243.82 712.78a±193.11 0.00b
42 1,606.00a±351.82 861.97a±279.86 0.00b
C3H/HeOuJ 22 1,332.52a±175.56 925.15a±240.80 0.00b
36 926.80a±65.85 1,226.80a±105.72 0.00b
42 850.10a±121.22 502.36a±45.58 0.00b
IgG1 BALB/c 22 B61,770.05a±7,021.37 B38,422.46b±4,290.84 B759.36c±9.56
36 A229,759.18a±9,217.51 B201,502.29a±20,013.75 A5,378.44b±23.64
42 B120,493.13a±23,430.8 AB106,204.12a±26,270.70 A5,092.74b±30.42
C3H/HeOuJ 22 B75,176.47a±2,766.60 B22,797.79b±4,329.10 B759.36c±8.79
36 A280,733.96a±2,683.72 A219,853.21a±14,141.12 A6,201.83b±420.19
42 AB152,733.96a±16,125.7 AB147,853.21±19,768.58 A6,078.27b±356.33
IgG2a BALB/c 22 B121.93±15.21 B111.89±7.10 B74.86±0.97
36 B2,145.90±535.27 B884.90±73.94 AB467.55±2.25
42 B1,510.69a±176.78 B671.07b±41.88 AB465.10b±3.61
C3H/HeOuJ 22 AB3,129.95±983.27 B156.68±8.60 B89.84±1.56
36 A43,321.23a±4,569.57 A31,762.25a±3,773.39 A1,135.86b±128.14
42 A24,821.23a±4,153.53 A21,786.15a±1,642.40 A1,100.24b±120.99
Values are means (ng/mL±SEM, n=5 per group) obtained for each mouse strain (BALB/c and C3H/HeOuJ) sensitized with 5, 1, or 0 (naïve) mg of OVA. 
a-cDifferent lowercase superscript letters indicate significant differences (P<0.01) within rows; A-BDifferent uppercase superscript letters indicate significant differ-
ences (P<0.05) within columns for each antibody (IgE, IgG1, or IgG2a).
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C3H/HeOuJ mice produced significantly more IgG2a than 
BALB/c mice. Unlike BALB/c mice, oral sensitization of C3H/
HeOuJ led to a significant IgG2a response, which was indepen-
dent of the sensitization dose and peaked on day 36 (Table).
Anaphylactic responses to OVA
Oral challenge with OVA-LPS-free led to a drop in body tem-
perature in C3H/HeOuJ mice which was significantly more 
pronounced in those sensitized with the lowest dose (1 mg) 
(Fig. 1A). The body temperature of orally challenged BALB/c 
mice was higher and not significantly different from that of their 
naïve counterparts. In fact, BALB/c mice only showed a signifi-
cant temperature drop when the allergen was i.p. administered 
(not shown).
Significant anaphylaxis signs were detected in sensitized 
BALB/c and C3H/HeOuJ mice following both oral challenges 
(Fig. 1B). Symptoms consisted of decreased activity, labored 
respiration, and difficulty in walking normally in both strains, 
but the responses were characterized by diarrhea in BALB/c 
mice, and scratching and puffiness around nose and mouth in 
C3H/HeOuJ mice. The anaphylactic scores were similar in both 
strains of mice regardless of the dose used for sensitization (Fig. 
1B), and there were no statistical differences in the severity of 
the symptoms elicited by the subsequent oral challenges or the 
i.p. challenge (data not shown). Similarly, the serum levels of 
mMCP-1 in sensitized mice were significantly higher than in 
naïve mice, but they did not change with the strain or the sensi-
tization dose (Fig. 2). 
Cytokine responses to OVA and influence of LPS 
contamination
Spleen-cell cultures from naïve mice of both strains produced 
low levels of cytokines following stimulation with OVA-LPS-free 
(Fig. 3A-E; white bars). In sensitized mice, stimulation of sple-
nocytes with OVA-LPS-free induced the production of signifi-
cantly more Th2-related cytokines, such as IL-13 and IL-5 (Fig. 
3A and B), and the Th1-related cytokine IFN-γ (Fig. 3D) in 
BALB/c mice than in C3H/HeOuJ mice, without a significant in-
fluence of the dose used for sensitization. OVA-LPS-free did not 
induce a significant release of TNF-α or IL-10 from spleen cells 
of sensitized BALB/c and C3H/HeOuJ mice and, in this case, 
there were no significant differences in the amount of these cy-
tokines produced by both strains, except in the levels of TNF-α 
generated by the spleen cells from naïve mice (Fig. 3C and E). 
Stimulation of splenocytes with OVA-LPS did not generate 
more Th2-related cytokines than OVA-LPS-free in any mouse 
strain (Fig. 3A and B). However, OVA-LPS significantly en-
hanced the production of the Th1-related cytokines TNF-α and 
IFN-γ in naïve and sensitized C3H/HeOuJ mice (Fig. 3C and D). 
Similarly, LPS-OVA stimulated the splenocytes of naïve and 
sensitized C3H/HeOuJ mice to produce IL-10, leading to high-
er levels of this cytokine than those induced by OVA-LPS-free 
(Fig. 3E). 
DISCUSSION
The present study assessed the antibody levels, severity of 
anaphylaxis, and Th1 and Th2 responses induced by OVA in 2 
different mouse strains of CT-primed, IgE-mediated food aller-
Fig. 1. Anaphylaxis in BALB/c and C3H/HeOuJ mice sensitized with 5, 1, or 0 (naïve) mg of OVA. Body temperature (A) and symptom scores (B), after the second oral 
challenge with 50 mg of OVA. Horizontal bars represent mean values for temperature and median values for scores (n=5). Different letters indicate statistically sig-
nificant differences (P<0.05). 
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gy: BALB/c and C3H/HeOuJ. The utility of different mouse 
models for the evaluation of the allergenic potential of proteins 
has been compared using i.p. sensitization;21,22 but even if expo-
sure to food allergens through non-oral routes, particularly 
through the skin, is increasingly being recognized as a factor 
which promotes sensitization over tolerance,23 the oral route is 
generally accepted as the most relevant. However, to the best of 
our knowledge, very few studies have made such a comparison 
using oral sensitization, most of them with cow’s milk and pea-
nut proteins administered to C3H/HeJ mice, which do not ex-
press TLR4.4,9,24 Considering the high shipping price to Europe 
of the C3H/HeJ mouse, broadly used in many food allergy stud-
ies,18,25 the use of its congenic C3H/HeOuJ, with functional 
TLR4, appears as a convenient alternative. Finally, because the 
mice selected were sensitive to the adjuvant activity of LPS, 
which is usually present in commercial proteins as a contami-
nant, we investigated the influence of LPS on the immunostim-
ulating capacity of OVA in spleen cells of naïve and sensitized 
mice of both strains. 
The 2 doses of OVA (1 and 5 mg) generated similar OVA-spe-
cific IgE and IgG1 levels in BALB/c and C3H/HeOuJ mice. 
However, we detected significantly higher OVA-specific IgG2a 
levels in C3H/HeOuJ mice, which suggests a Th1 bias in this 
mouse strain.26 According to Berin et al.,4 there are no differenc-
es between BALB/c and C3H/HeOuJ mice in the IgE and IgG1 
responses to lactoglobulin (β-Lg), although C3H/HeOuJ mice 
produce higher peanut protein-specific IgE and IgG1 levels 
than BALB/c mice. However, Smit et al.24 reported higher con-
centrations of peanut-specific IgE and IgG1 in BALB/c mice 
and higher concentrations of IgG2a in C3H/HeOuJ, a discrep-
ancy that was attributed to differences in the peanut sensitiza-
tion protocols.
Fig. 3. Cytokine levels―IL-13 (A), IL-5 (B), TNF-α (C), INF-γ (D), and IL-10 (E) ―
produced by spleen cells of BALB/c and C3H/HeOuJ mice sensitized with 5, 1, 
or 0 (naïve) mg of OVA and incubated in the presence of OVA-LPS-free and 
OVA-LPS for 72 hours. Values are means and SEM. Different letters indicate 
statistically significant differences (P<0.05) between spleen cells cultured with 
OVA-LPS-free. *indicates P<0.05 between OVA-LPS-free and OVA-LPS.
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While OVA seemed equally immunogenic in both mouse 
strains, as judged by its capacity to generate IgE and IgG1 anti-
bodies, oral challenge induced a more pronounced tempera-
ture drop in C3H/HeOuJ than in BALB/c mice. Regarding the 
severity of clinical signs following oral challenge with OVA, 
there were no significant differences between the mouse strains 
or the 2 oral doses used for sensitization in the anaphylaxis 
scores, although there was a non-significant tendency to higher 
scores in the C3H/HeOuJ strain sensitized with the lowest dose. 
It should be noted that there were differences in the type of 
clinical symptoms developed, which suggests the convenience 
of using different scoring systems for both strains. Similarly, se-
rum levels of mMCP-1, a protease released by activated intesti-
nal mast cells, which is indicative of mast-cell degranulation, 
were significantly increased in the sensitized mice as compared 
to their naïve controls, but there were no significant differences 
between C3H/HeOuJ and BALB/c mice.
In view of our own results and of previous findings, it can be 
pointed out that whereas systemic symptoms are strain-depen-
dent, they also vary with the antigen used for immunization.22 
Thus, orally sensitized BALB/c mice are totally resistant to pea-
nut protein-induced anaphylaxis even in the presence of high 
specific serum IgE levels.4,9,24 Anaphylactic reactions to β-Lg are 
also less severe in BALB/c mice than in C3H/HeOuJ mice.4 Sen-
sitized C3H/HeOuJ mice develop OVA-specific IgE and ana-
phylaxis on challenge,7 but there are also examples of BALB/c 
mice successfully sensitized to OVA by the gastrointestinal 
route with the aid of CT,14,19,27 anti-acid medication28 or oil emul-
sion plus salicylate,29 which develop clinical symptoms of IgE- 
or IgG1-mediated anaphylaxis upon oral challenge. 
Stimulation of spleen cells with OVA led to a significantly 
higher production of Th2 (IL-5 and IL-13) and Th1 (IFN-γ) cy-
tokines in the BALB/c strain than in the C3H/HeOuJ strain. 
Berin et al.4 and Smit et al.24 also reported that spleen cells of 
peanut-sensitized BALB/c mice generated more IL-4, IL-5, IL-
13, and IFN-γ than those of C3H/HeOuJ mice. Moreover, the 
secretion of high amounts of IFN-γ together with Th2 cytokines, 
following OVA stimulation of sensitized animals, is considered 
a characteristic feature of BALB/c mice.19 As expected, the pres-
ence of LPS contamination in the stimulating protein induced 
the production of IFN-γ and TNF-α and thus it led to a skewing 
of the cytokine response to a Th1 phenotype, although it also 
promoted IL-10. LPS is a TLR4 ligand that enhances Th1 or 
Th17 responses but suppresses Th2 immunity.2 It is a common 
contaminant of commercial protein preparations, and it is doc-
umented that it promotes the release of TNF-α, IL-6, IL-1β, and 
IL-10 by spleen cells of naïve BALB/c mice.16 It is noteworthy 
that the influence of LPS was much more pronounced in naïve/
sensitized C3H/HeOuJ mice than in BALB/c mice. Therefore, 
while factors different from TLR4 functionality influence the 
susceptibility to sensitization and allergic manifestation in mice 
with a BALB/c or a C3H background,4 our results indicate that, 
in the presence of a functional LPS receptor, the presence of 
contaminant LPS affected the immunostimulating capacity of 
proteins differently depending on the mouse strain. The anti-
body and cytokine profiles induced by OVA in BALB/c mice, 
with low levels of OVA-specific IgG2 and high levels of IL-13 
and IL-5, argue against a predominant Th1 response in this 
strain that could inhibit Th2-mediated food allergic reactions.9 
Furthermore, BALB/c spleen cells proved to be more resistant 
than those of C3H/HeOuJ mice to the stimulus of a Th1-polar-
izing agent such as LPS.
In our study, there was no clear relationship between the sen-
sitization dose and the antibody, anaphylactic, and cytokine re-
sponses in any of the strains. In this respect, Li et al.18,25 reported 
that lower oral doses of cow’s milk and peanut proteins plus CT 
were more effective than higher doses in inducing higher spe-
cific IgE concentrations and more severe anaphylactic reac-
tions in mice.
In conclusion, we were able to induce allergy to OVA in BALB/
c and C3H/HeOuJ mice, establishing appropriate sensitization 
and challenge doses. The results showed that both strains ex-
hibited similar susceptibility to OVA sensitization, although oral 
challenge provoked more severe manifestations in C3H/HeOuJ 
mice than in BALB/c mice. Stimulation of spleen cells with OVA 
led to significantly higher levels of Th2 and Th1 cytokines in the 
BALB/c strain than in the C3H/HeOuJ strain, and these were 
less affected by protein contamination with LPS. The response 
of the splenocytes from BALB/c to OVA stimulation, releasing 
higher concentrations of Th2- and Th1-related cytokines, ren-
ders this strain more adequate than the C3H/HeOuJ strain to 
study the features of OVA that make it immunogenic and the 
factors promoting sensitization, as well as to understand the 
mechanisms underlying the efficacy of immunotherapy treat-
ments with this allergen. In addition, the observation of mea-
surable clinical symptoms (in particular, diarrhea) following 
oral and systemic challenges of BALB/c mice with OVA also 
points at its suitability to estimate the safety of those treatments.
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